Skip to Content

75 (Risedronate Sodium Delayed-Release 35 mg)

Pill with imprint 75 is Yellow, Round and has been identified as Risedronate Sodium Delayed-Release 35 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 75

Risedronate Sodium Delayed-Release

Imprint
75
Strength
35 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
68382-0075

Get help with Imprint Code FAQs.

Related Images for "75"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.